Richard Carvajal, MD, discusses how to make decisions regarding the dosing limits of immunotherapy agents.
Richard Carvajal, MD, from Columbia University Medical Center discusses deciding on dosing limits for immunotherapy treatments.
The proper dosing for immunotherapy efficacy is unclear. For chemotherapy, the patients can often be pushed to toxicity. However, with immunotherapies and targeted therapies, there are responses seen after 1 or 2 doses. There are also durable responses in some patients if treatment is stopped.
Patients Are Concerned About Developing an Opioid Addiction Following Mohs Microscopic Surgery
August 1st 2023Patients about to undergo Mohs microscopic surgery reported that they were more likely to request over-the-counter medications if they perceived their risk of opioid addiction to be high.